Overall rank by patents
#29,930
Across all tracked assignees
USPTO PatentsView assignee record - 9 granted patents across 3 technology areas, active 2016–2021. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C02F (TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE).
The verdict
Reverse holds 9 US patents across 3 technology areas, rank #29,930 of 50,000 tracked assignees.
Reverse Ionizer Systems, Llc has been granted 9 US utility patents between 2016 and 2021, placing Reverse Ionizer Systems, Llc at rank #29,930 across all assignees tracked by PlainPatent. This portfolio spans 3 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.8 claims per patent with primary concentration in C02F (TREATMENT OF WATER, WASTE WATER, SEWAGE, OR SLUDGE). As a US Corporation, Reverse Ionizer Systems, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Reverse sits between Renovo Software, Inc. (9 patents, rank #29,926) and Rio Grande Neurosciences, Inc. (9 patents, rank #29,934) - the closest US assignees by grant volume. The composite Innovation Score of 24.7/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 3 grants, compared with 6 in the 2015–2019 window, a -50% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Reverse Ionizer Systems, Llc's 17.8 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while specialization in 3 subclasses reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Reverse Ionizer Systems, Llc against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Renovo Software, Inc.
9 patents
Research Cancer Institute of America
9 patents
Retrace Labs
9 patents
Retrocausal, Inc.
9 patents
Ri.MED Foundation
9 patents
RideFlux Inc.
9 patents
Rimports, LLC
9 patents
Rio Grande Neurosciences, Inc.
9 patents
Reverse Ionizer Systems, LLC
9 patents
What this shows Reverse holds 9 patents at rank #29,930, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #29,930 in granted patent volume.
Other assignees with the most granted patents in Reverse's primary technology class.
Reverse's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
25 Top 85% higher than 15% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2016 | 3 | 33.3% |
| 2017 | 1 | 11.1% |
| 2019 | 2 | 22.2% |
| 2020 | 2 | 22.2% |
| 2021 | 1 | 11.1% |
Top 3 of 3 technology areas
Overall rank by patents
#29,930
Across all tracked assignees
24.7 out of 100
How to use this portfolio
Reverse's 9 grants land it in the top 85% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.